Capecitabine‐containing regimens vs chemotherapy regimens without capecitabine
Overall survivalmedian · neoadjuvant treatment of ER‐positive vs ER‐negative breast cancer
Capecitabine‐containing regimens showed no clear difference in overall survivalmedian compared with non‐capecitabine‐containing regimens (high certainty).
1 finding from 1 review
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes onlyHR 0.97 [0.77, 1.23]4 studies · 2499 participantsHigh